Fact-checked by Grok 2 weeks ago

Azoxystrobin

Azoxystrobin is a broad-spectrum, systemic strobilurin widely used in to control fungal diseases in crops such as cereals, fruits, , and turf. It belongs to the β-methoxyacrylate class of compounds, inspired by naturally occurring strobilurins produced by basidiomycete fungi like Strobilurus tenacellus, and was the first commercialized member of this group, launched in 1996 by ICI (now part of ) under brand names including Quadris and Amistar. Chemically known as methyl (E)-2-{2-[6-(2-cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3-methoxyacrylate, azoxystrobin has the molecular formula C22H17N3O5 and a molecular weight of 403.4 g/mol. It appears as a white crystalline solid with a melting point of 116 °C, low water solubility (6 mg/L at 20 °C), and moderate lipophilicity (log P of 2.5), which contributes to its systemic uptake in plants and persistence in soil (Koc range of 207–594). Azoxystrobin's mode of action targets the Qo binding site of the cytochrome bc1 complex in fungal mitochondria, inhibiting electron transport between cytochromes b and c1, which disrupts respiration and leads to fungal death; this mechanism provides protective, curative, and eradicant effects against a wide range of pathogens, including Septoria tritici, Pyricularia oryzae, and Plasmopara viticola. Developed through synthetic optimization of natural strobilurins discovered in the , azoxystrobin revolutionized crop protection by offering high at low doses (typically 0.1–0.3 kg/ha) and improving yield and quality in treated crops. It is applied preventively or curatively to major crops like , grapes, potatoes, bananas, and soybeans, as well as non-crop areas such as courses, where residues have been detected at levels up to 1.76 mg/kg in grapes. While azoxystrobin exhibits low to mammals (LD50 >5000 mg/kg oral in rats) and is rapidly metabolized and excreted, it is highly toxic to organisms (LC50 <1 mg/L for fish) and has a half-life of 8–12 weeks under aerobic soil conditions, prompting regulatory monitoring for environmental impact. By the early 2000s, it had become the world's best-selling fungicide, underscoring the strobilurin class's dominance in modern agriculture.

Chemical Characteristics

Molecular Structure

Azoxystrobin has the chemical formula \ce{C22H17N3O5} and a molecular weight of 403.39 g/mol. The molecule consists of a central pyrimidine ring substituted at the 4- and 6-positions with aryloxy groups: the 4-position links via oxygen to a phenyl ring that bears the (E)-β-methoxyacrylate side chain at its 2-position, while the 6-position connects similarly to a 2-cyanophenyl group. This arrangement features key functional groups including a nitrile on the cyanophenyl, an enoate ester and enol ether in the methoxyacrylate moiety, and ether linkages facilitating the overall aryloxypyrimidine scaffold. The β-methoxyacrylate pharmacophore, with its (E) configuration at the C=C double bond, is critical for enabling QoI fungicidal activity by mimicking the binding to the quinone outer site in fungal respiration. Azoxystrobin represents a synthetic analog of natural strobilurins, antifungal compounds isolated from basidiomycete fungi such as Strobilurus tenacellus (source of strobilurin A) and Oudemansiella mucida (source of strobilurin X), which share the conserved β-methoxyacrylate core responsible for mitochondrial inhibition but differ in their variable aromatic side chains. Unlike the labile natural products, azoxystrobin incorporates a stable pyrimidine-based linker and cyano substituent to enhance photostability, systemic uptake, and broad-spectrum efficacy against fungal pathogens. The crystal structure of azoxystrobin has been elucidated through X-ray crystallography, deposited in the Cambridge Crystallographic Data Centre (CCDC deposition DOI: 10.5517/ccqdksf), providing insights into its planar conformation and intermolecular interactions in the solid state that influence polymorphism and formulation stability.

Physical and Chemical Properties

Azoxystrobin appears as an off-white to beige crystalline solid in its technical grade form, which facilitates its handling and formulation into agricultural products. This physical state contributes to its stability during storage and application. The compound exhibits a melting point of 116°C, indicating moderate thermal stability suitable for typical environmental and processing conditions encountered in fungicide use. Its low volatility is evidenced by a vapor pressure of 1.1 × 10^{-10} Pa at 20°C, which minimizes atmospheric dispersion and supports targeted soil and foliar applications. Solubility characteristics are key to its behavior in various media: azoxystrobin has low aqueous solubility of approximately 6 mg/L at 20°C and neutral pH, limiting its mobility in water while enhancing persistence on treated surfaces. In contrast, it shows higher solubility in organic solvents, such as 94–258 g/L in acetone at 20°C, aiding in the preparation of emulsifiable concentrates and wettable powders. Azoxystrobin demonstrates hydrolytic stability across a range of values relevant to natural environments, with no significant degradation (<10% loss) observed after 30 days at 25°C in pH 5 and 7 buffers; at pH 9 and elevated temperature (50°C), the half-life is about 12 days. It is moderately photostable, with a half-life of 8.7–13.9 days under simulated Florida summer sunlight conditions at pH 7 and 25°C. The octanol-water partition coefficient (log K_{ow}) of 2.5 at 20°C reflects moderate lipophilicity, influencing its partitioning between soil organic matter and water phases. These properties collectively contribute to azoxystrobin's low leaching potential in soils, as its limited water solubility and low vapor pressure reduce off-site transport.
PropertyValueConditionsSource
AppearanceOff-white to beige crystalline solidTechnical gradeFAO (2015)
Melting point116°CPurity ≥98%FAO (2015)
Solubility in water6 mg/L20°C, neutral FAO (2015); EPA (1997)
Solubility in acetone94–258 g/L20°CFAO (2015)
Vapor pressure1.1 × 10^{-10} Pa20°CFAO (2015)
Hydrolytic stabilityStable ( >30 days)25°C, 5–7FAO (2015)
Photostability 8.7–13.9 days25°C, 7, FAO (2015)
Log K_{ow}2.520°C, 7FAO (2015)

History and Development

Discovery

Azoxystrobin's discovery traces back to the identification of natural compounds from basidiomycete fungi, particularly the mycelial extracts of the wood-rotting mushroom Strobilurus tenacellus. In 1977, a team of researchers led by Timm Anke and Franz Oberwinkler isolated two novel antibiotics, strobilurin A and strobilurin B, from liquid cultures of this fungus as part of a systematic screening for microbial metabolites with potential. These compounds exhibited strong inhibitory effects against fungal , highlighting their promise as leads for new fungicides. The structural elucidation of strobilurin A was conducted by Wolfgang Steglich's group at the , who determined its core β-methoxyacrylate in 1978, a feature common to several natural strobilurins produced by basidiomycetes for defense against competing microbes. However, early structural assignments encountered challenges, including an initial misassignment of the side-chain , which was corrected to the active 9Z by Anke et al. in 1984, with ICI researchers confirming it through comparative and spectroscopic in the 1980s. This refinement was crucial for understanding the molecule's and guiding analog development. Drawing inspiration from these natural strobilurins, particularly strobilurin A, scientists at (ICI) launched a targeted in the early 1980s to create synthetic derivatives with enhanced stability against environmental degradation, such as photolysis—a key limitation of the natural compounds. By 1984, ICI's early laboratory screening of initial synthetic analogs demonstrated potent broad-spectrum activity, surpassing that of the parent natural products in efficacy and persistence. The ICI team, including chemists like V. M. Anthony, systematically explored structural modifications, synthesizing approximately 1,400 analogs to optimize the toxophore while improving systemic uptake and resistance to metabolic breakdown. This iterative process, grounded in strobilurin scaffold, culminated in azoxystrobin's selection as a lead candidate, with initial patents filed in marking the transition from natural discovery to synthetic innovation.

Commercialization and Milestones

Azoxystrobin was first commercialized in 1996 by Zeneca, the successor to (ICI), under the brand name Amistar, with initial production and sales commencing at a dedicated facility in , . This launch marked the introduction of the first strobilurin-class fungicide to the market, stemming from ICI's foundational patents on its synthetic routes. By 1999, azoxystrobin had achieved regulatory registration in 48 countries for application on over 50 crops, reflecting rapid global expansion driven by its broad-spectrum efficacy. In 2000, it received Millennium Product status, recognizing its innovative contribution to . Production capacity for azoxystrobin continued to grow with Syngenta's expansion of its facilities in 2023, increasing global supply by 15% to meet rising demand. In the United States, agricultural usage reached approximately 1,000,000 kg in 2017, underscoring its widespread adoption in crop protection. The global market for azoxystrobin is projected to reach approximately $2,200 million by 2031, supported by ongoing innovations such as the launch of new granular formulations by Heben in 2023-2024, which enhance application efficiency for farmers, and the 2025 introduction of a new azoxystrobin-based product by Sipcam Nichino in .

Synthesis

Key Synthetic Routes

The industrial synthesis of primarily follows a multi-step substitution pathway that assembles the from readily available precursors, with the key being methyl (E)-2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate. This is generated through sequential etherification of a precursor with 4,6-dichloropyrimidine followed by construction of the β-methoxyacrylate moiety, ensuring the desired (E)- at the vinyl . The pivotal final step involves nucleophilic aromatic substitution, where the intermediate reacts with 2-cyanophenol (or its potassium salt) under basic conditions, displacing the chlorine at the 6-position of the pyrimidine ring. This coupling is efficiently catalyzed by 1,4-diazabicyclo[2.2.2]octane (DABCO) at 0.5–5 mol% loading in solvents like N,N-dimethylformamide or toluene, proceeding at elevated temperatures (80–120°C) to afford azoxystrobin in high yield. Industrial implementations of this route achieve overall yields exceeding 90% for the final step, with product purity routinely surpassing 98% after crystallization, while maintaining stereoselectivity for the active (E)-isomer through controlled reaction conditions and purification. Alternative synthetic routes to azoxystrobin incorporate variations in forming the critical vinyl linker, notably employing the to couple a ylide derived from methoxymethyltriphenylphosphonium chloride with an appropriate aldehyde precursor, such as 2-(6-chloropyrimidin-4-yloxy). Although this approach generates an (E/Z) mixture requiring chromatographic separation to isolate the bioactive (E)-, it offers flexibility in early-stage assembly and has been adapted in laboratory-scale optimizations. Post-2000 developments have emphasized environmentally benign processes to minimize waste, exemplified by a concise route utilizing cross-coupling between 2-bromophenol-derived boronic acids and (Z)-methyl 2-iodo-3-methoxyacrylate, followed by substitution; this method avoids toxic reagents like , employs aqueous solvent mixtures, and delivers azoxystrobin in >95% yield for key steps with non-hazardous byproducts.

Patent and Production Details

The original patent for azoxystrobin and related strobilurin fungicides was filed by (ICI) in 1984, following the discovery of the compound class inspired by natural strobilurins from mushrooms. The specific compound patent, EP 0 382 375, was filed by ICI in 1989 and granted in 1993, covering the synthesis and fungicidal use of azoxystrobin (then coded ICIA5504). In the United States, equivalent protection under patents such as US 5,395,837 extended until early 2014, after which generic entry was permitted. Following ICI's , (later ) held key rights, including process patents like US 8,124,761 for methods, which remained valid until 2029. and its predecessors secured numerous related patents—over 100 globally—for analogs, formulations, and combinations, such as EP 2004194 for liquid mixtures with and US 9,192,159 for stable suspensions. These protections supported commercial dominance until post-patent competition intensified. Global production capacity for azoxystrobin has expanded significantly since commercialization, reaching approximately 4,500 tons annually by 2013, with major producers including and firms such as Taihe Chemicals and Yangnong Chemical. As of 2025, capacity exceeds 10,000 tons per year, driven by demand in and the scale-up of synthetic routes enabling efficient industrial production. The expiration of core compound patents in 2014 facilitated the entry of low-cost generics from manufacturers, reducing prices by up to 50% and increasing market accessibility. Quality control in azoxystrobin production adheres to standards set by the U.S. Environmental Protection Agency (EPA) and (FDA), requiring technical-grade material to contain at least 96.5% (965 g/kg) . These specifications, aligned with EPA registration requirements, are verified through and reverse-phase HPLC methods during manufacturing.

Mechanism of Action

Biochemical Target

Azoxystrobin targets the Qo site (also known as the quinol oxidation site or QP site) within the (complex III) of the in fungi. This binding occurs in the subunit, where azoxystrobin competes with for the Qo pocket, preventing the oxidation of . The primary mode of action involves inhibition of electron transfer from ubiquinol to the Rieske iron-sulfur protein and subsequently to cytochrome c1, disrupting the proton gradient across the inner mitochondrial membrane and halting ATP synthesis via oxidative phosphorylation. The simplified reaction catalyzed at the Qo site, which azoxystrobin blocks, is: \text{Ubiquinol} + 2 \text{ Cyt } c_{\text{ox}} \rightarrow \text{Ubiquinone} + 2 \text{ Cyt } c_{\text{red}} + 2\text{H}^+ Azoxystrobin exhibits high affinity for the , with IC50 values in the low nanomolar range (approximately 1 nM for bacterial models used to study fungal targets). This potency is evident in both fungal and mammalian , though overall mammalian toxicity is low, indicating selectivity beyond direct binding affinity. X-ray crystallographic studies of the bacterial bound to azoxystrobin reveal key interactions at the Qo site, including hydrogen bonding between the methoxyacrylate carbonyl group and residues like Glu-295, as well as positioning of the planar methoxyacrylate moiety near the of for steric and electronic stabilization. These structural details confirm the precise fit of azoxystrobin's methoxyacrylate within the conserved Qo pocket, essential for its fungicidal efficacy.

Fungicidal Activity and Spectrum

Azoxystrobin exhibits systemic, translaminar, and protective activity, allowing it to move through tissues via the stream to provide both preventative and curative control against fungal infections. It primarily prevents spore germination and inhibits mycelial growth by disrupting fungal energy production, leading to rapid cessation of fungal development and death within hours due to energy deficiency. Unlike some pesticides, azoxystrobin has no direct phytotoxic effects on , ensuring its action is targeted solely at fungal pathogens. The demonstrates a broad spectrum of activity, effective against major fungal groups including Ascomycetes, Basidiomycetes, Deuteromycetes, and , responsible for various plant diseases. This wide-ranging efficacy makes it suitable for controlling diverse pathogens such as those causing , rusts, leaf spots, and downy mildews across multiple crop types. Azoxystrobin is highly efficient at low application rates, typically 0.1-0.5 kg per , depending on the and disease pressure, which minimizes environmental exposure while maintaining strong control. It becomes rainfast within 2 hours of application, resisting wash-off and ensuring sustained protection even in wet conditions. Beyond direct fungicidal effects, azoxystrobin indirectly benefits plant health by enhancing through improved CO2 assimilation and delaying leaf senescence, which can lead to higher yields even in the absence of severe disease.

Applications

Agricultural and Crop Protection

Azoxystrobin plays a critical role in large-scale agricultural protection by providing broad-spectrum control against key fungal pathogens that threaten yield and quality in major field crops. It is registered for use on over 50 crops worldwide, including cereals such as and , like tomatoes and potatoes, and fruits including grapes and bananas, with recent EPA tolerances established in 2023 for (4 ppm), (6 ppm), and (0.06 ppm). In the United States, it is extensively applied to field corn and soybeans, which account for a significant portion of its agricultural deployment. The fungicide effectively targets prominent diseases such as leaf rust (Puccinia spp.) in cereals, powdery mildew (Erysiphe spp.) in vegetables and fruits, Septoria leaf blotch (Septoria tritici) in wheat, and anthracnose (Colletotrichum spp.) in grapes and bananas. These diseases can cause substantial defoliation, reduced photosynthesis, and lower harvestable yields if unmanaged. Application methods include foliar sprays at rates of 0.1-0.3 kg active ingredient per hectare, typically timed to coincide with early disease onset or high-risk periods, and seed treatments that deliver early-season protection against soilborne and seedling pathogens. Its translaminar and systemic uptake ensures protective distribution within plant tissues for extended coverage. In the , azoxystrobin usage reached approximately 1,000,000 kg annually by 2019 (latest available USGS data as of 2024), with primary applications on corn and soybeans to mitigate foliar and diseases. This widespread adoption has contributed to yield increases of up to 10-20% in treated fields across cereals and , by preserving area and enhancing vigor against infection pressure.

Horticultural and Non-Crop Uses

Azoxystrobin is widely applied in home and garden settings to manage common turfgrass diseases, particularly brown patch caused by and dollar spot caused by Sclerotinia homoeocarpa. In residential lawns, it provides preventive and curative control when applied at rates of 0.4 to 1.2 fluid ounces per 1,000 square feet, typically in mixtures like those found in consumer products such as DiseaseEx Lawn Fungicide. These applications help maintain healthy turf without the need for professional equipment, with reapplication intervals of 14 to 28 days depending on disease pressure. In ornamental , azoxystrobin protects flowers, shrubs, and nursery stock from foliar diseases including black spot () on roses and rusts caused by and Uromyces species. Application rates for ornamentals range from 0.05 to 0.15 kg per , often delivered in 100 gallons of spray volume per for thorough coverage of foliage. This systemic uptake allows the to distribute within plant tissues, offering protection against both existing and incoming infections in landscape plantings around homes and public spaces. For turf management on amenity areas like golf courses and sports fields, azoxystrobin is employed to suppress diseases such as brown patch, dollar spot, and , while also supporting overall turf vigor through improved stress tolerance and color retention. It is applied preventively at 0.4 to 0.8 fluid ounces per 1,000 square feet to high-traffic areas, helping to sustain playability and aesthetic quality throughout the growing season. In non-crop contexts, azoxystrobin serves as a for forestry seedlings, such as including Christmas trees, to control damping-off and tip blights like those caused by Diplodia species. Its use in veterinary applications remains limited, primarily to indirect protections in treated feed or environments rather than direct animal treatments. Consumer-oriented products containing azoxystrobin, such as ready-to-use sprays, are available for home gardeners targeting diseases on and non-commercial , providing convenient options for small-scale applications. These formulations maintain the same broad-spectrum activity against fungal pathogens as in agricultural uses, focusing on preventive measures in backyard settings.

Formulations

Product Forms

Azoxystrobin is commercially available in several formulation types designed for effective delivery in agricultural applications. The most common forms include , typically at concentrations of 250 g/L, which provide a stable aqueous of fine particles for foliar sprays. , often at 25% (250 g/L), allow for easy mixing with to form emulsions suitable for spray applications. , commonly at 500 g/kg, dissolve readily in to form a , offering convenience in handling and reduced dust compared to powders. For seed treatments, azoxystrobin is formulated as flowable suspensions, such as those at 100 g/L, enabling uniform coating on for systemic against soil-borne pathogens. Recent innovations include granular forms launched in 2024 to enhance application ease and precision in field use. Additionally, nanoencapsulated versions have been explored in studies; a 2024 study examined their induced hepatic and renal toxicity in rats, which was mitigated by co-administration of nanoparticles. As of October 2025, research on alginate-based nanoformulations shows potential for controlled release in managing and diseases. These formulations often incorporate adjuvants, such as , to improve adhesion to plant surfaces and enhance uptake efficiency. Azoxystrobin products are generally compatible with many other active ingredients when properly mixed, supporting approaches. Storage stability is a key feature, with formulations remaining effective for 2 years at (5–30°C) when kept in sealed, original packaging away from direct and extreme conditions.

Compatibility and Application Methods

Azoxystrobin demonstrates broad tank-mix with most registered insecticides, herbicides, and liquid fertilizers, allowing for applications in agricultural settings. However, physical should always be verified through a jar test prior to large-scale mixing, as or separation may occur with certain adjuvants or . It is generally incompatible with highly alkaline or acidic solutions, which can degrade the or . Common application techniques for azoxystrobin include foliar sprays for protective coverage on leaves and stems, soil drenches to target root and crown pathogens, and seed coatings for early-season protection against seedling diseases. Applications are most effective when initiated at early disease stages or as a preventative measure before infection pressure builds, ensuring systemic uptake and translaminar movement within plant tissues. Dosage guidelines emphasize preventative use, with typical rates varying by crop and disease but often ranging from 0.1 to 0.5 kg per , applied at 7- to 14-day intervals under moderate conditions to maintain protective residues. Shorter intervals within this range are recommended during high-risk periods, such as humid weather favoring fungal sporulation, while exceeding three consecutive applications without rotation is discouraged. Standard ground equipment, such as boom sprayers, is widely used for azoxystrobin applications, with configurations producing medium to coarse droplets (100-300 μm) to optimize coverage and minimize drift. Aerial or chemigation methods are also suitable for larger fields, provided volumes of at least 50 gallons per ensure uniform distribution. Best practices for azoxystrobin use include rotating with non-QoI (Group 11) fungicides, such as those from FRAC Groups 3 or M, after every two to three applications to delay development in target pathogens. This , combined with integrated cultural practices like proper spacing and , enhances long-term efficacy while reducing selection pressure on fungal populations.

Human Safety and Toxicology

Toxicity Profile

Azoxystrobin exhibits low acute toxicity across multiple exposure routes. The oral LD50 in rats exceeds 5000 mg/kg body weight, indicating minimal risk from ingestion, while the dermal LD50 surpasses 2000 mg/kg body weight in the same species, showing low absorption through the skin. Inhalation LC50 values are 0.962 mg/L for male rats and 0.698 mg/L for females over a 4-hour exposure, further confirming its low acute hazard profile. Regarding irritation and sensitization, azoxystrobin causes only slight irritation to rabbit skin and eyes, with effects resolving within 48 hours and no persistent damage observed. It is not a dermal sensitizer, as demonstrated in studies using the Magnusson-Kligman maximization test. In chronic toxicity assessments, a 2-year feeding study in s established a (NOAEL) of 18 mg/kg body weight per day, based on reduced body weights and lesions at higher doses; no evidence of carcinogenicity was found in rats or mice. Azoxystrobin is not genotoxic and has not been classified as an . Reproductive and developmental toxicity studies in rats and rabbits showed no adverse effects, with NOAELs of at least 165 mg/kg body weight per day in multigeneration rat studies and 100-500 mg/kg body weight per day in developmental assays. Azoxystrobin is rapidly and extensively metabolized in mammals, primarily via O-demethylation, , and conjugation with , leading to less toxic metabolites. These metabolites are quickly excreted, with 82-90% elimination within 48 hours, mainly through feces (73-89%) and urine (9-18%), minimizing accumulation. exposure primarily occurs through dermal contact and during , with low dietary residues due to rapid and degradation.

Regulatory Tolerances and Exposure Limits

The (ADI) for azoxystrobin is established at 0–0.2 mg/kg body weight per day by the Joint FAO/WHO Meeting on Pesticide Residues (JMPR). This value supports dietary risk assessments worldwide and is based on data, with a safety factor applied. In the United States, the Environmental Protection Agency (EPA) updated maximum residue limits (MRLs) for azoxystrobin in 2023 to accommodate imports, establishing tolerances of 4 ppm for , 6 ppm for , and 0.06 ppm for . The acute population-adjusted dose (aPAD), equivalent to an acute reference dose (ARfD) of 0.5 mg/kg body weight, is used for short-term exposure assessments, confirming no acute dietary risks from these residues. The (EFSA) assessed and supported modification of the MRL for azoxystrobin in in 2023, raising it from 30 to 40 mg/kg; the EU later aligned its MRL for with the CXL of 4 mg/kg adopted in December 2023, with no identified concerns for residues in rotational crops. These updates ensure consumer exposure remains below the ADI of 0.2 mg/kg body weight, as verified through chronic intake modeling. The Commission adopted new Codex maximum residue limits (CXLs) in December 2023 for azoxystrobin in (4 mg/kg) and (0.06 mg/kg), facilitating . These CXLs were derived from JMPR evaluations and support global standards without exceeding health-based limits. Canada's Pest Management Regulatory Agency initiated a re-evaluation consultation for azoxystrobin in 2023, proposing continued registration based on updated risk assessments, with no major regulatory bans implemented as of 2025. This aligns with ongoing approvals in major markets, including an extension to 2027.

Environmental Impact

Environmental Fate

Azoxystrobin undergoes aerobic in primarily through microbial processes, with a DT50 ranging from 13 to 17 days under conditions at 20°C, though values can vary widely up to 56–279 days depending on type and environmental factors. In water-sediment systems, is faster, with a DT50 of approximately 6 days in the water phase, driven by and photolysis. The compound exhibits moderate mobility in , characterized by a Koc value of 300–760 mL/g, indicating potential for limited while strongly binding to and reducing transport through profiles. Primary degradation pathways include microbial breakdown, which mineralizes azoxystrobin to CO2 over time, and on and surfaces, producing metabolites such as the derivative and Z-isomer. In plants, azoxystrobin dissipates with a half-life of 8–30 days, depending on crop type and conditions, reflecting rapid metabolism and translocation. Bioaccumulation is low, with a bioconcentration factor (BCF) below 100 in aquatic organisms, attributed to its moderate log Kow of 2.5 and limited uptake. Azoxystrobin's low volatility (vapor pressure <10^{-6} Pa) minimizes atmospheric loss, but runoff poses a risk, with detections in surface waters following rainfall events in agricultural areas, often at concentrations up to 30 μg/L. Regulatory bodies monitor azoxystrobin in surface waters, with California's chronic human health reference level set at 0.36 μg/L as of 2024, reflecting concerns over persistence and bioaccumulation risks.

Ecotoxicological Effects

Azoxystrobin exhibits high toxicity to aquatic crustaceans, with a 48-hour LC50 as low as 0.04 mg/L reported for sensitive clones of Daphnia magna, highlighting substantial risk to these non-target invertebrates in freshwater ecosystems. In contrast, its toxicity to fish is high, with 96-hour LC50 values ranging from 0.2 to 5 mg/L depending on life stage; for example, zebrafish larvae (Danio rerio) show an LC50 of 0.39 mg/L, while juveniles exhibit 2.90 mg/L, indicating potential sublethal effects such as impaired development and respiration at environmentally relevant concentrations. These impacts are exacerbated by azoxystrobin's moderate solubility and persistence in water, which influence exposure levels to aquatic biota. On terrestrial systems, azoxystrobin demonstrates low to , with a 14-day LC50 exceeding 100 mg/kg dry soil for species like Eisenia foetida. Similarly, honeybees ( mellifera) experience minimal risk, as evidenced by acute oral and LD50 values greater than 100 μg/bee. However, certain metabolites of azoxystrobin can pose risks to aquatic plants, including alterations in activity and cellular damage in macrophytes like Myriophyllum quitense following acute exposure to commercial formulations. Azoxystrobin presents low acute risks to birds and mammals, with oral LD50 values surpassing 2000 mg/kg body weight for species such as bobwhite quail (Colinus virginianus) and rats. Among degradation products, the R135808 exhibits greater toxicity to compared to the parent compound, potentially amplifying ecological disruptions in communities. Recent research indicates that nanoparticles can mitigate toxicity from nanoencapsulated azoxystrobin forms, reducing and organ damage in exposed organisms, which suggests potential strategies for lowering ecotoxicological impacts in aquatic environments.

Resistance Management

Resistance Development

Azoxystrobin is classified by the Fungicide Resistance Action Committee (FRAC) in Group 11, the Quinone outside Inhibitors (QoI), a category characterized by a high risk of development owing to its single-site mode of action that targets the Qo site on the protein in the fungal mitochondrial . This specificity makes QoI s particularly vulnerable to mutations that confer , as even minor genetic changes at the target site can render the compound ineffective against fungal populations. The earliest documented instances of resistance to azoxystrobin emerged in 1998, with reports of reduced sensitivity in populations of wheat powdery mildew ( f. sp. tritici) in shortly after the fungicide's introduction. By the early 2000s, resistance had spread rapidly to cereal crops across , , and , affecting pathogens such as Septoria tritici (causal agent of septoria leaf blotch) and various rust fungi, driven by the fungicide's widespread adoption without adequate rotation practices. At the molecular level, the predominant mechanism of resistance involves point mutations in the gene (cyt b). The G143A substitution is the most common and confers high-level resistance across many fungal by altering the binding affinity of azoxystrobin to its target site, while the F129L mutation appears in select pathogens like Cercospora nicotianae and provides moderate resistance with potentially lower fitness costs to the fungus. These mutations have been identified through sequencing and sensitivity assays in field isolates, highlighting the genetic basis for the rapid observed. FRAC's ongoing monitoring, detailed in annual working group reports and pathogen risk lists, tracks resistance in over 50 fungal species worldwide as of 2025, with confirmed cases in key such as (gray mold) and (early blight). For instance, high frequencies of G143A mutants have been reported in populations from grapevines and strawberries, while strains from tomatoes and potatoes show widespread insensitivity. In the 2024/25 season, high frequencies of QoI continued to be reported in various pathosystems through bioassays and molecular studies. Globally, trends indicate a significant prevalence by , with high frequencies reported in many monitored fields in major crop-producing regions like and , particularly in cereals and . This escalation has been linked to overuse, including repeated seasonal applications and reliance on QoI-only formulations, which select for resistant genotypes and reduce the fungicide's long-term efficacy in integrated disease management.

Management Strategies

Effective management of resistance to azoxystrobin, a QoI fungicide (FRAC Group 11), relies on proactive strategies that minimize selection pressure on fungal populations while maintaining disease control. These approaches are guided by the Fungicide Resistance Action Committee (FRAC) recommendations, which emphasize integrated practices to extend the utility of this high-risk chemistry across crops such as cereals, , and fruits. Rotation is a cornerstone of resistance prevention, with FRAC advising that azoxystrobin applications be limited to no more than one-third of the total seasonal fungicide sprays to reduce exposure frequency. Alternation should occur with fungicides from unrelated FRAC groups, such as demethylation inhibitors (Group 3, e.g., tebuconazole), succinate dehydrogenase inhibitors (Group 7, e.g., boscalid). This strategy has been shown to delay resistance onset in pathosystems like Septoria leaf blotch in wheat, where overuse led to widespread shifts in sensitivity. Mixing azoxystrobin with fungicides of different modes of action further dilutes risk by requiring multiple mutations for survival. Premixes or tank mixtures with multi-site protectants, such as (FRAC Group M3), provide broad-spectrum coverage without promoting single-site , while combinations with single-site actives like azoles (e.g., , FRAC Group 3) target complementary pathways. For instance, in rust management, such mixtures have sustained efficacy where solo QoI applications failed due to . Integration into (IPM) programs enhances sustainability by combining chemical controls with cultural and biological tactics. Regular field scouting to detect early disease symptoms allows applications at established economic thresholds, reducing unnecessary sprays, while planting resistant or tolerant crop cultivars minimizes reliance on fungicides altogether. In vegetable production, this IPM approach has lowered azoxystrobin use by up to 50% without yield losses, as demonstrated in and cucurbit trials. Recent FRAC updates for 2024-2025 underscore dose optimization, recommending full label rates to maximize and suppress low-level , particularly in high-disease-pressure scenarios. New combination products, such as Miravis Neo (containing azoxystrobin, , and pydiflumetofen from FRAC Groups 11, 3, and 7, respectively), exemplify these guidelines by providing multi-mode protection in row crops like corn and soybeans. Ongoing is essential to track shifts and inform adjustments. Bioassays, such as mycelial growth inhibition on amended media with azoxystrobin at discriminatory concentrations (e.g., 1-10 mg/L), detect resistant isolates efficiently, with values indicating population-level changes. Regional FRAC reports, compiled from collaborative surveys, provide real-time data on baselines and emerging risks, enabling localized strategy refinements. For example, annual bioassays in grape-growing areas have guided rotations to avert QoI failures in control.

Commercial Aspects

Brand Names

Azoxystrobin is marketed under various brand names by major agricultural companies, often in standalone formulations or mixtures for specific applications such as foliar sprays, turf management, or seed treatments. , the original developer, offers several prominent brands including Amistar, a broad-spectrum first introduced in 1996 for crop protection. Other products include Quadris for agricultural use, specifically formulated for turf and ornamental applications, and as a primarily in the to control early-season diseases in crops like corn. Bayer CropScience markets azoxystrobin-containing products such as Sparkle, a with difenoconazole targeted at fungal diseases in crops like and potatoes in regions including . brands have proliferated since the core expiration around early 2014, enabling production by various manufacturers. Notable examples include Azoxystar from Albaugh LLC, available as a 250 g/L suspension concentrate for broad-spectrum disease control. In the , particularly for cereals, P from (formerly part of portfolio) combines azoxystrobin with for and other foliar diseases. Numerous generics, such as 25% SC formulations, are produced by firms like Suli Chemical and companies including UPL Limited, offering cost-effective alternatives for global markets. The global market for azoxystrobin reached approximately $980 million in 2025, driven by expanding agricultural applications and is projected to grow at a (CAGR) of 14.3%, reaching $2.2 billion by 2034. This growth reflects the fungicide's broad-spectrum efficacy against key pathogens in major crops, supporting higher yields amid rising global food demands. Key drivers include surging demand in the region, particularly for and protection, where azoxystrobin is widely used to combat diseases like rice blast and fruit rots, accounting for a significant portion of regional consumption. Innovations such as smart delivery systems, including pH-responsive nano-formulations introduced in 2024, have enhanced application efficiency and reduced dosage requirements, further boosting adoption. Production of azoxystrobin is concentrated in major hubs, with holding over 60% of the market share due to its extensive manufacturing capacity and low-cost production. Switzerland-based , the original developer, remains a pivotal player through its innovation and , while generics have dominated since the core expiration around 2014, enabling broader accessibility and price competition. However, challenges persist, including fungal development that limits long-term efficacy and stringent regulations that can restrict sales in sensitive markets; for instance, ongoing resistance monitoring has prompted integrated management recommendations to sustain product value. Counterbalancing these, the U.S. Agency's 2023 expansions of residue tolerances for crops like , , and have facilitated increased use in , enhancing market penetration. Looking ahead, the market outlook emphasizes sustainable formulations to mitigate environmental concerns, with projections indicating a shift toward eco-friendly nano-encapsulated and biodegradable delivery systems by 2030 to align with global regulatory pressures and trends. These advancements are expected to address resistance and runoff issues while maintaining azoxystrobin's role in , particularly in high-growth areas like .